← Back to Short Term Strategy

Short Term Strategy · Research Note

ICRA

Holding horizon · 1m · 3m · 6mTarget: Active, high-probability setups

This name has since left the Short Term Strategy screen — the note is kept for reference.

“The intelligent investor is a realist who sells to optimists and buys from pessimists.”

— Benjamin Graham
Price

₹4,296

Market cap

₹4,122.48 Cr

Price ÷ Earnings

20.96×

Price ÷ Book

3.49×

Return on capital

21.55%

The scorekeeper nobody notices

Every cricket match has a scorer sitting quietly at the boundary, marking each run, each wicket, each over. Nobody claps for him. Yet if he stops, or if you cannot trust his book, the whole game descends into an argument. ICRA is that scorer for India's debt market. When a company or a bank wants to borrow money by selling bonds, someone has to tell lenders how likely they are to be repaid. ICRA assigns that grade — AAA, AA, and so on down the alphabet — and lenders price their money off it. It is a small business by revenue, but it sits at a chokepoint that the entire credit system must pass through.

The company was born in 1991, seeded by banks and financial institutions, and today the global rating giant Moody's stands behind the promoter block. That parentage matters, because credibility is the only product a rating agency actually sells.

Why a fallen price is what caught our eye

Here is the plain fact that pulled ICRA into a short-horizon shortlist: the stock has been taken to the woodshed. Down 27% over the past year, and off from a high of ₹6,982 to a recent low near ₹4,692, it now trades at ₹4,845 — a whisker above its worst level. The three-year price return is *negative*, even as the business underneath kept growing. That gap between a sulking share price and a working business is the sort of thing a short-term strategy is built to exploit.

And the business has genuinely been working. Sales sat almost flat for years — ₹322 crore in FY15, still only ₹328 crore by FY19, and actually dipping to ₹301 crore in the pandemic year of FY21. That decade-long crawl is why the ten-year sales growth reads a limp 6%. But look at what happened after: ₹343 crore, then ₹403, ₹446, ₹498, and a projected ₹600 crore for FY26. The five-year sales growth is 15% and the trailing twelve months clock 20%. The scorer, having been idle for years, is suddenly being asked to keep a lot more books. Profit has followed the same arc — from ₹83 crore in FY21 to a projected ₹183 crore in FY26.

Through all of this, the share count has not moved a millimetre. Equity capital has been frozen at ₹10 crore for eleven straight years. No rights issues, no bonus-fuelled optics, no ESOP flood quietly clipping your slice. Every rupee of that rising profit accrues to the same number of owners. For a short-term holder this is underrated comfort — there is no dilution overhang waiting to spring on you.

What the market is charging today

Now the part that earns the position. ICRA trades at a P/E of 25. Against its own five-year median of 47.1, that is a discount of roughly 47%. Against its ten-year median of 44.8, a discount of about 44%. Put simply, this stock has historically been priced at something close to double the multiple it wears today. You are being asked to pay half of what buyers of ICRA have normally paid for its earnings stream — and you are paying it while the top line grows faster than it has in a decade.

The quality underneath supports a premium, not a discount. Return on capital employed sits at 23%, return on equity at a steady 16-17% year after year, and the company is almost debt-free. It pays out a little over half its profit as dividend, giving you a 1.47% yield to collect while you wait. This is an asset-light franchise that needs almost no capital to grow — the ideal profile for a business you would want to own cheaply.

The other side of the ledger

I will not pretend the discount is a free gift. Rating agencies live and die by trust, and that trust is fragile. India has not forgotten the IL&FS and DHFL episodes, where highly-rated paper turned to dust and every rating agency, ICRA included, took reputational and regulatory blows. That memory is part of why the multiple has compressed — the market is nervous that a rating scandal can arrive without warning. On a one-to-six-month view, any adverse SEBI action or a headline default in a name ICRA rated could hurt the price fast.

There are quieter warnings too. FIIs have trimmed from 8.15% to 6.90% over the recent stretch, so the smart foreign money has been drifting out even as domestic institutions nudged their stake up. The book value is ₹1,223, meaning you are paying nearly four times book — this is not Graham-cheap on assets, it is cheap only relative to its own earnings history.

The verdict for a short holding

The case here is clean and narrow. A high-return, debt-free, non-diluting franchise, growing revenue at its fastest pace in ten years, is being offered at roughly half its own long-run earnings multiple after a bruising 27% fall. For a one-to-six-month strategy, that mean-reversion setup is exactly the pitch you want to swing at — provided you keep the position sized for the reputational landmine that all rating agencies carry. *Buy the discount, but keep your stop and your patience close by.*

More Short Term Strategy namesYour dashboard